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Butylated hydroxytoluene (BHT) which is widely used as an anti-oxidant in food has been found to induce 
the differentiation of rnurine erythroleukemia cells. BHT also amplifies the differentiation inducing 
activity of DMSO. 
Butylated hydroxytoluene Differentiation Erythroleukemia cell DMSO 
1. INTRODUCTION 
During the studies on the differentiation-induc- 
ing substances of animal cells, we found that butyl- 
ated hydroxytoluene (BHT) induces the differen- 
tiation of murine erythroleukemia cells. 
medium and fetal bovine serum were obtained 
from GIBCO and Flow Laboratory, respectively. 
DMSO was a product of Junsei Chemical Co. 
(Tokyo). 
2.2. Cell line and cell culture 
BHT is widely used as an antioxidant or a sta- 
bilizer in food, feed, cosmetics and pharmaceutical 
products. Recently it has been reported that BHT 
shows a variety of biological activities; e.g., inac- 
tivation of viruses [2,3], antimutagenicity [4], anti- 
carcinogenesis [5-71, and stimulation of DNA syn- 
thesis [8]. 
Mouse erythroleukemia cells (clone B8) [9] were 
kindly provided by Dr K. Nose. Cells were grown 
in Ham’s F12 medium supplemented with 15% 
fetal bovine serum and kanamycin (60 pg/ml) at 
37°C in a humidified incubator with 8% COZ 
atmosphere. 
We report here that BHT also induces the dif- 
ferentiation of murine erythroleukemia cells with 
high efficiency, and amplifies the differentiation- 
inducing activity of DMSO. 
2.3. Differentiation assay 
2. MATERIALS AND METHODS 
The cells (6 x lo4 cells/ml) were cultured for 3-7 
days at 37°C with the indicated concentrations of 
BHT (see text) and/or 1.5% DMSO. The differen- 
tiated cells were determined by the modified 
benzidine-staining method [lo]. 
2.1. Materials 3. RESULTS AND DISCUSSION 
Butylated hydroxytoluene (BHT) was purchased 
from Wako Chemical Co. (Tokyo). Ham’s F12 
Studies on the differentiation inducing substances of 
animal cells II. See [I] 
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3.1. Effect of BHT on growth and differentiation 
of mouse rythroleukemia cells 
After the erythroleukemia cells were cultured 
with the various concentrations of BHT for 3 days, 
the differentiated cells were determined by the 
benzidine-staining method. Fig. 1 shows that the 
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Fig.1. Effect of BHT on growth (A) and differentiation 
(B) of mouse erythroleukemia (B8) cells. The cells (6 x 
lo4 cells/ml) were cultured for 3 days at 37°C with the 
indicated concentrations of BHT in 5 ml of Ham’s F12 
medium supplemented with 15% fetal bovine serum in 
humidified air containing 8% COZ. The differentiated 
cells were examined by the benzidine-staining method 
191. 
differentiation occurs at about 30 Fg/ml of BHT 
maximally. 
3.2. Time-course analysis of the differentiation 
induced by BHT and DMSO 
Time-course of differentiation was examined 
(fig.2). M~imum cell differentiation by BHT was 
observed after 3 days culture, whereas maximum 
differentiation induction by DMSO was observed 
after 6 days culture. 
3.3. Cooperative effect of BHT and DMSO on the 
differentiation of erythroleukemia cells 
Fig.3 shows the cooperative effect of 1.5% 
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Fig. 2. Time-course analysis of differentiation by 30 
@g/ml of BHT (0) and 1.5% DMSO (m). The culture 
conditions and examination method of the differentiated 
cells were the same as described in the legend of fig. 1, 
BHT has been reported to possess a variety of 
biological activities; e.g., inactivation of viruses 
[2,3], anti-mutagenic activity [4], inhibition of 
physical [S] and chemical [6,7] car~inogenesis and 
the stimulation of DNA synthesis [S]. It was 
recently reported that BHT inhibits cell differen- 
tiation of mouse myeloid leukemia (M 1) cells [ 161 
induced by dexamethasone at the concentration of 
10 pug/ml [17]. 
except the days in culture. We have described here that BHT is a highly ef- 
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Fig. 3. Cooperative effect of 1.5% DMSO and the 
different concentrations of BHT on growth (A) and 
differentiation (B) of mouse erythroleukemia (BS) cells. 
The cells were cultured for 6 days with 1.5% DMSO and 
the indicated concentrations of BHT (o), and with BHT 
only (0). The experimental details are described in the 
legend of fig. 1, except the days in culture (this 
experiment was repeated 3 times, and the results were 
confirmed). 
DMSO and the indicated concentrations of BHT 
on the growth (A) and the differentiation (B) of 
mouse erythroleukemia (Bg) cells. The cells were 
cultured for 6 days with 1.5% DMSO and the 
various concentrations of BHT (o), and with BHT 
only (0). This figure shows inducibility of about 
0% with BHT at the concentration range of 5-2.5 
pglml, and of about 40% with DMSO, respective- 
ly. Inducibihties, however, by the cooperation of 
DMSO and BHT (5-25 pg/ml) were higher than 
the sums of inducibilities caused by the individual 
inducers. Somewhat weak synergism was ob- 
served, 
BHT is a strong antioxidant. Other antioxidants 
such as retinoic acid [l l-131, tocopherol 17,141 and 
ascorbic acid [7,15] are also known to inhibit car- 
cinogenesis or to influence cell differentiation. The 
redox system might take part in the mechanisms of 
differentiation and carcinogenesis. 
278 
Volume 165, number 2 FEBS LETTERS January 1984 
ficient inducer of differentiation. The fact that 
BHT, a widely used reagent, has differentiation 
controlling activity might present a serious pro- 
blem to embryogenesis or development of animals. 
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